In this study, we demonstrated that hepatocyte Smad4 expression stimulated CXCL1 secretion via the ASK1, P38 MAPK, and JNK signaling pathways, thereby promoting the progression of NAFLD. Here, CXCL1 is linked to metabolic dysfunction-associated steatotic liver disease.